Literature DB >> 1619081

Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies.

W R Gammon1, J D Fine, M Forbes, R A Briggaman.   

Abstract

The autoimmune subepidermal bullous diseases are characterized by autoantibodies to the basement membrane zone of stratified squamous epithelium. Recent studies have shown that the antibodies have characteristic ultrastructural and antigenic binding properties and that differentiating between those properties can be useful in distinguishing one disease from another. Immunofluorescence microscopy is widely used to detect basement membrane zone autoantibodies. The test has traditionally used tissue substrates with an intact basement membrane zone. Those substrates are limited because autoantibody binding cannot always be detected and because autoantibodies with different ultrastructural and antigenic binding properties cannot be distinguished from each other. Normal human skin that has been separated through the basement membrane zone (i.e., split skin) has recently been used as a substrate for detecting and characterizing basement membrane zone autoantibodies by immunofluorescence. Studies indicate that split skin is a more sensitive substrate than intact skin for detecting the antibodies and that antibodies with different ultrastructural binding sites can often be differentiated from one another on split skin. Those studies suggest split skin is the substrate of choice for the routine immunofluorescence evaluation of autoimmune subepidermal bullous diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1619081     DOI: 10.1016/0190-9622(92)70161-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

Review 1.  Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist.

Authors:  Roberto Verdolini; Rino Cerio
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

Review 2.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

4.  The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.

Authors:  H Schumann; J Baetge; K Tasanen; F Wojnarowska; H Schäcke; D Zillikens; L Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

5.  Epidermolysis bullosa acquisita--successful treatment with colchicine.

Authors:  M Megahed; K Scharffetter-Kochanek
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.

Authors:  Janet A Fairley; Matthew Bream; Colleen Fullenkamp; Sergei Syrbu; Mei Chen; Kelly N Messingham
Journal:  J Am Acad Dermatol       Date:  2012-10-18       Impact factor: 11.527

7.  Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases.

Authors:  Emilia Licarete; Susanne Ganz; Martin J Recknagel; Giovanni Di Zenzo; Takashi Hashimoto; Michael Hertl; Giovanna Zambruno; Gheorghe Hundorfean; Jonas Mudter; Markus F Neurath; Leena Bruckner-Tuderman; Cassian Sitaru
Journal:  BMC Immunol       Date:  2012-04-04       Impact factor: 3.615

8.  Bullous systemic lupus erythematosus associated with esophagitis dissecans superficialis.

Authors:  Meera Yogarajah; Bhradeev Sivasambu; Eric A Jaffe
Journal:  Case Rep Rheumatol       Date:  2015-03-02

Review 9.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 10.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.